-+ 0.00%
-+ 0.00%
-+ 0.00%

ALDEYRA THERAPEUTICS RESUBMITS REPROXALAP NEW DRUG APPLICATION FOR THE TREATMENT OF DRY EYE DISEASE

Reuters·06/17/2025 11:00:01

Please log in to view news